Effectiveness of infliximab in patients with Behçet syndrome and severe uveoretinitis. Report of five cases;Eficacia del infliximab en pacientes con síndrome de Behçet portadores de úveo-retinitis grave

Revista Medica de Chile

Volumn 134, Issue 7, 2006, Pages 875-882

  Merino, Guillermo ^a,b   Varas, Gonzalo ^c   Díaz, Gonzalo ^d   Gutiérrez, Miguel ^c   Massardo, Loreto ^c   Pacheco, Daniel ^d   Villarroel, Francisco ^e   Cuchacovich, Miguel ^f,g,h  

^a CLÍNICA SANTA MARÍA   (Chile)

^b Centro Oftalmológico Luis Pasteur   (Chile)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d UNIVERSITY OF CHILE   (Chile)

^e Fundacion Oftalmologica Los Andes   (Chile)

^f HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^g CLÍNICA LAS CONDES   (Chile)

^h Oficina 607   (Chile)

Author keywords

Beh et syndrome; Infliximab; Retinitis; Uveitis

Indexed keywords

ANTIINFLAMMATORY AGENT; INFLIXIMAB; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; BEHCET DISEASE; CASE REPORT; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MALE; MIDDLE AGED; RETINITIS; UVEITIS; VISUAL ACUITY;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; BEHCET SYNDROME; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; MALE; MIDDLE AGED; RETINITIS; UVEITIS; VISUAL ACUITY;

EID: 33748501286     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. KAKLAMANI VG, VAIOPOULOS G, KAKLAMANIS G. Behçet's disease. Semin Arthritis Rheum 1998; 27: 197-217.
2. SAKANE T, TAKENO M, SUZUKI N, INABA G. Behçet's disease. N Engl J Med 1999; 341: 1284-91.
3. NUSSENBLATT RB. Uveitis in Behçet's disease. Int Rev Immunol 1997; 14: 67-79.
4. NAKAMURA S, YAMAKAWA T, SUGITA M, KIJIMA M, ISHIOKA M, TANAKA S ET AL. The role of tumor necrosis factor-alpha in the induction of experimental autoimmune uveoretinitis in mice. Invest Ophthalmol Vis Sci 1994; 35: 3884-9.
5. SARTANI G. Anti-tumor necrosis alpha therapy suppresses the induction of experimental autoimmune uveitis uveoretinitis in mice by inhibiting antigen priming. Invest Ophthalmol Vis Sci 1996; 37: 2211-8.
6. SAGAWA K, ITO K, SAKAGUCHI M, TAMAI M, SUGITA S, MUKAIDA N ET AL. Production of IL-8 and the other cytokines by T cell clones established from the ocular fluid of patients with Behçet's disease. Ocul Immunol Inflamm 1995; 3: 63-71.
7. NAKAMURA S, SUGITA M, TANAKA T, OHNO S. In vitro tumor necrosis factor-alpha producibility in peripheral monocytes in patients with Behçet's disease. Nippon Ganka Gakkai Zasshi 1992; 96: 1282-5.
8. LIPSKY PE, VAN DER HEIJDE DM, ST CLAIR EW, FURST DE, BREEDVELD FC, KALDEN JR ET AL. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000; 343: 1594-602.
9. CUCHACOVICH M, FERREIRA L, ALISTE M, SOTO L, CUENCA J, CRUZAT A ET AL. TNF-α levels and influence of -308 TNF-α promoter polymorphism on the responsiveness to infliximab in patients with rheumatoid arthritis. Scand J Rheumatol 2004; 33: 228-32.
10. SFIKAKIS PP, THEODOSSIADIS PG, KATSIARI CG, KAKLAMANIS P, MARKOMICHELAKIS NN. Effect of infliximab on sight-threatening panuveitis in Behçet's disease. Lancet 2001; 58: 295-6.
11. OHNO S, SATOSHI N, HORI S, SHIMAKAWA M, KAWASHIMA H, MOCHIZUKI M ET AL. Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis. J Rheumatol 2004; 31: 1362-8.
12. LACOMBA SM, MARTIN MC, GALLARDO GALERA JM, GÓMEZ VIDAL MA, COLLANTES ESTÉVEZ E, RAMÍREZ CHAMOND R ET AL. Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis. Ophthalmic Res 2001; 33: 251-5.
13. CUCHACOVICH M, MERINO G, YAMAMOTO J, VILLARROEL F, SAAVEDRA T, JOFRÉ S ET AL. Behçet's disease patients present high levels of deglycosylated anti-lipoteichoic acid IgG and high IL-8 production after lipoteichoic acid stimulation. Clin Exp Rheumatol 2005; 23: S27-S34.
14. MANCUSO G, TOMASELLO F, OFEK I, TETI G. Anti-Lipoteichoic acid antibodies enhance release of cytokines by monocytes sensitized with lipoteichoic acid. Infect Immun 1994; 62: 1470-3.
15. MUÑOZ-FERNÁNDEZ S, HIDALGO V, FERNÁNDEZ-MELÓN J, SCHLINCKER A, MARTÍN MOLA E. Effect of infliximab on threatening panuveitis in Behçet's disease. Lancet 2001; 358: 1644.
16. HAUGEBERG G, VELKEN M, JOHNSEN V. Successful treatment of genital ulcers with infliximab in Behçet's disease. Ann Rheum Dis 2004; 63: 744-5.
17. CAMBIEN B, BERGMEIER W, SAFFARIPOUR S, MITCHELL HA, WAGNER DD. Antithrombotic activity of TNF-alpha. J Clin Invest 2003; 112: 1589-96.
18. ROSENBAUM JT. Blind Insight: Eyeing anti-tumor necrosis factor treatment in uveitis associated with Behçet's Disease. J Rheumatol 2004; 31: 1241-3.